Financial statements Central Europe Genomics Center
Balance sheet of Central Europe Genomics Center
Company age:
Age:
10 y. 21 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of CENTRAL EUROPE GENOMICS CENTER
|
Year
|
2018
|
2019
|
2020
|
2021
|
|---|---|---|---|---|
| Total assets | 100 287,13 | 3 356 833,85 | 7 291 840,03 | 9 114 595,20 |
| A. Fixed assets | 0,00 | 3 167 000,00 | 3 167 000,00 | 3 167 880,00 |
| B. Current assets | 100 287,13 | 189 833,85 | 4 124 840,03 | 5 946 715,20 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 100 287,13 | 3 356 833,85 | 7 291 840,03 | 9 114 595,20 |
| A. Equity | 6 800,00 | -5 121,40 | 587 802,66 | 1 892 284,45 |
| B. Liabilities and provisions for liabilities | 91 275,97 | 3 361 955,25 | 6 704 037,37 | 7 222 310,75 |
| I. Long-term liabilities | 0,00 | - | 0,00 | 0,00 |
| II. Short-term liabilities | 91 275,97 | - | 6 704 037,37 | 7 222 310,75 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.